Showing results (2621-2630 of 3,872) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|April 24, 2014
ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progressionVanessa Paiva Leite de Sousa, Claudia Bessa Pereira Chaves, Janina Ferreira Loureiro Huguenin, et al.Cancer Biology & Therapy|May 8, 2014
Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracilJing Gao, Jin Gao, Lan Qian, et al.Cancer Biology & Therapy|October 1, 2016
Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cellsSohei Matsumura, Tsuyoshi Ohta, Keiko Yamanouchi, et al.Cancer Biology & Therapy|November 21, 2013
First line treatment of metastatic renal cell carcinoma: two standards with different toxicity profileRoberto Iacovelli, Elena Verzoni, Filippo De Braud, et al.Cancer Biology & Therapy|November 21, 2013
PQJS380: a novel lead compound to induce apoptosis in acute lymphoblastic leukemia cellsXiaohui Zhu, Li Chen, Sheng Jiang, et al.Cancer Biology & Therapy|July 22, 2014
Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristineJohn Wong, Lisa T Tran, Eli A Magun, et al.Cancer Biology & Therapy|July 22, 2014
Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferationZhen Zhao, Rui Li, Sha Sha, et al.Cancer Biology & Therapy|July 22, 2014
Ipilimumab: a potential immunologic agent in the treatment of metastatic castration-resistant prostate cancerAdam Kittai, Mariam Meshikhes, Jeanny B Aragon-ChingCancer Biology & Therapy|August 29, 2013
A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitorsAna A Tula-Sanchez, Aaron P Havas, Peter J Alonge, et al.Pageof 388